David Bouchey

Stock Analyst at Aegis Capital

(0)
# 5342
Out of 5,386 analysts
7
Total ratings
Success rate
Average return
5 Stocks
Name Action PT Current % Upside Ratings Updated
SBFM Sunshine Biopharma
Reiterates: Buy
15 15
1.45 934.48% 2 Dec 5, 2024
STSS Sharps Technology
Initiates Coverage On: Buy
105600
n/a n/a 1 May 9, 2023
ATXI Avenue Therapeutics
Initiates Coverage On: Buy
2400
n/a n/a 1 Apr 3, 2023
IINN Inspira Technologies...
Maintains: Buy
10 13
0.82 1485.37% 1 Jan 25, 2023
RMTI Rockwell Medical
Downgrades: Outperform
121
0.8 15025% 2 Oct 19, 2018